Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Pedunculopontine Nucleus Transcranial Ultrasound Stimulation for Freezing of Gait in Parkinson's

Official title: Pedunculopontine Nucleus Transcranial Ultrasound Stimulation as a Treatment of Freezing of Gait in Parkinson's Disease

Run by University Health Network, Toronto · NCT07695233 · Data updated 2026-11-12

This study tests whether targeted ultrasound stimulation of the Pedunculopontine nucleus can reduce freezing of gait in people with Parkinson’s disease.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedMay 17, 2024
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedJuly 10, 2026
Trial IDNCT07695233 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-90 with a confirmed Parkinson’s disease diagnosis and freezing of gait, on stable dopaminergic therapy for at least 4 weeks.

Probably not a fit

Individuals with significant cognitive impairment, implanted devices, or contraindications to MRI or TUS may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will apply transcranial ultrasound stimulation to the Pedunculopontine nucleus in adults with Parkinson’s disease and freezing of gait. It uses a randomized, cross-over design to compare excitatory, inhibitory, and sham stimulation, with gait analyses and patient-reported outcomes to assess safety, tolerability, and impact on freezing of gait. Imaging, including rsfMRI and ASL, will examine brain connectivity and perfusion changes, and structural MRI will guide individualized stimulation parameters. The study enrolls 25 PD patients with FOG and 25 matched healthy controls to characterize effects and mechanisms. Primary outcomes focus on gait metrics and quality of life, while secondary analyses explore functional connectivity and safety signals via MRI.

Why it matters

Potential benefit: If successful, patients may experience reduced freezing episodes and improved mobility and quality of life.

How similar studies have gone: Previous work in neuromodulation and targeted brain stimulation for gait has shown promise, but this exact PPN-TUS approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-90 years of age
* Confirmed diagnosis of a movement disorder with Freezing of Gait
* Stable dopaminergic medication dose for a minimum of 4 weeks

Exclusion Criteria:

* History of stroke or seizure
* Comorbid dementia
* Scored below 22 on the Montreal Cognitive Assessment (MoCA)
* Has intracranial implant(s) or device(s)
* Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD)
* Has a previous surgical intervention to treat the movement disorder such as lesioning or a DBS system in place.
* Presence of metal implanted in body that is contraindicated in TMS/MRI
* Pregnancy
* Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study
* Is on antipsychotics, marijuana, or other recreational drugs that affect the nervous system
* Major musculoskeletal or neuromuscular disease or disorder of the hands, wrists and limbs
* Major systemic illness or infection

Where it's running

  • Toronto Western Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Robert Chen, MD — University Health Network, Toronto
  • Study coordinator: Julian Kwok
  • Email: julian.kwok@uhn.ca
  • Phone: 416-603-5800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.